» Articles » PMID: 23045606

Neuropilin 1 Deficiency on CD4+Foxp3+ Regulatory T Cells Impairs Mouse Melanoma Growth

Abstract

Infiltration of Foxp3(+) regulatory T (T reg) cells is considered to be a critical step during tumor development and progression. T reg cells supposedly suppress locally an effective anti-tumor immune response within tumor tissues, although the precise mechanism by which T reg cells infiltrate the tumor is still unclear. We provide evidence that Neuropilin 1 (Nrp-1), highly expressed by Foxp3(+) T reg cells, regulates the immunological anti-tumor control by guiding T reg cells into the tumor in response to tumor-derived vascular endothelial growth factor (VEGF). We demonstrate for the first time that T cell-specific ablation of Nrp-1 expression results in a significant breakdown in tumor immune escape in various transplantation models and in a spontaneous, endogenously driven melanoma model associated with strongly reduced tumor growth and prolonged tumor-free survival. Strikingly, numbers of tumor-infiltrating Foxp3(+) T reg cells were significantly reduced accompanied by enhanced activation of CD8(+) T cells within tumors of T cell-specific Nrp-1-deficient mice. This phenotype can be reversed by adoptive transfer of Nrp-1(+) T reg cells from wild-type mice. Thus, our data strongly suggest that Nrp-1 acts as a key mediator of Foxp3(+) T reg cell infiltration into the tumor site resulting in a dampened anti-tumor immune response and enhanced tumor progression.

Citing Articles

Immunomodulation by allograft endothelial cells.

Bose S, Do V, Testini C, Jadhav S, Sailliet N, Kho A Front Transplant. 2025; 4:1518772.

PMID: 39967861 PMC: 11832486. DOI: 10.3389/frtra.2025.1518772.


The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy.

Guo R, Wang P Breast Cancer. 2024; 32(2):227-241.

PMID: 39589625 DOI: 10.1007/s12282-024-01654-7.


Contemporaneous Inflammatory, Angiogenic, Fibrogenic, and Angiostatic Cytokine Profiles of the Time-to-Tumor Development by Cancer Cells to Orchestrate Tumor Neovascularization, Progression, and Metastasis.

Skapinker E, Aucoin E, Kombargi H, Yaish A, Li Y, Baghaie L Cells. 2024; 13(20.

PMID: 39451257 PMC: 11506673. DOI: 10.3390/cells13201739.


Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.

Zhang H, Felthaus O, Eigenberger A, Klein S, Prantl L Cells. 2024; 13(18.

PMID: 39329710 PMC: 11429654. DOI: 10.3390/cells13181526.


Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy.

Zhou Z, Xu J, Liu S, Lv Y, Zhang R, Zhou X Biomark Res. 2024; 12(1):97.

PMID: 39227959 PMC: 11373505. DOI: 10.1186/s40364-024-00630-9.


References
1.
Solomon B, Mueller C, Chae W, Alabanza L, Bynoe M . Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2011; 108(5):2040-5. PMC: 3033275. DOI: 10.1073/pnas.1008721108. View

2.
Straume O, Akslen L . Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma. Angiogenesis. 2004; 6(4):295-301. DOI: 10.1023/B:AGEN.0000029408.08638.aa. View

3.
Pan Q, Chanthery Y, Liang W, Stawicki S, Mak J, Rathore N . Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell. 2007; 11(1):53-67. DOI: 10.1016/j.ccr.2006.10.018. View

4.
Takahashi Y, Kitadai Y, Bucana C, Cleary K, Ellis L . Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995; 55(18):3964-8. View

5.
Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z . CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008; 322(5899):271-5. DOI: 10.1126/science.1160062. View